CONFIDENTIAL INFORMATION
EMBARGOED UNTIL 00:01 ON THURSDAY 27th June
Tolley announces the development of Tolley+ AI, as industry report reveals that two thirds of UK tax professionals have already embraced AI.
The report reveals that more than 66% of UK tax professionals either use generative AI on a regular basis or intend to do so soon, noting that an AI solution grounded in unrivalled tax content from Tolley will transform the tax industry.
London – 27th June 2024 – Tolley®, part of LexisNexis® Legal and Professional, a leading provider of tax information, workflow and analytics, today announced the development of Tolley+ AI™, a generative AI solution designed to transform tax research and guidance. Grounded in the largest repository of accurate and exclusive tax content, Tolley+ AI combines the power of generative AI with proprietary search technology. Results on Tolley+ AI will always be backed by a verifiable, citable authority or source allowing users to check the validity of results instantly and effortlessly.
Tolley+ AI is using the same underlying and proven technology that drives Lexis+ AI®, the generative AI tool for lawyers. Following the successful launches of Lexis+ AI in the USA, Australia and the UK, the business is leveraging the global expertise and experience of over 2,000 technologists, data scientists and subject matter experts to develop, test and validate an AI solution specifically for the UK tax industry.
The role of generative AI in the UK tax market is of growing interest and importance. The new Tolley® report How Generative AI is Transforming Tax Practice reveals that UK tax professionals have been quick to recognise the efficiency benefits of generative AI. The survey of 446 UK tax professionals in private and in-house practice reveals that 66% of tax professionals are either using or plan to use AI for work purposes.
The report goes on to reveal that 32% of tax professionals in private practice have made AI-related changes to their day-to-day operations. In-house tax teams are a step ahead of their private practice colleagues, with 43% saying they have changed their ways of working, including 24% adopting new AI policies, 18% launching AI-powered tools for internal use and 14% delivering staff training.
Despite the interest in AI, 79% of UK tax professionals have some level of concern over the ethics and trustworthiness of public-access and free-to-use generative AI platforms citing “lack of trust” and “potential content hallucinations” as their main concerns. However, 71% said they would be “somewhat” or “completely comfortable” using AI-powered tools that were grounded in proven, authoritative tax research and guidance content.
Tolley+ AI is grounded in up-to-date and exclusive Tolley tax content. Tolley+ AI will be able to provide answers to tax questions with results that are always linked back to the underlying source. Tolley+ AI will feature conversational search, insightful summarisation, intelligent drafting and document upload capabilities, all supported by state-of-the-art encryption and privacy technology to keep sensitive data secure.
“AI is set to transform and revolutionise the practice of tax and it is clear that tax professionals are keen to embrace the value that generative AI can offer” commented Jon Scriven, Director of Tax Markets at Tolley.
Gerry Duffy, Managing Director at LexisNexis UK added “By combining our advanced technological capabilities with outstanding Tolley tax research and guidance content, we will be able to help our customers accelerate their workflows, increase productivity and gain a clear competitive advantage.”
Tolley is responsibly developing an AI solution with human oversight. As part of the LexisNexis and RELX family, AI development at Tolley follows the RELX Responsible AI Principles, considering the real-world impact of its solutions on people and taking action to prevent the creation or reinforcement of unfair bias.
To support tax professionals in their understanding of AI and the opportunities it will present, Tolley has created the Tolley+ AI™ Insider program. This will offer free and exclusive access to webinars, thought leadership and breaking news on the latest AI technologies. Curated by Tolley, there will be insights from tax market leaders, innovation and technology evangelists and in-house experts. Tolley+ AI Insiders will be among the first to experience the Tolley+ AI platform.
To read the report How Generative AI is Transforming Tax Practice and become a Tolley+ AI Insider, visit https://www.lexisnexis.co.uk/research-and-reports/tax-generative-ai-report-2024.html
About LexisNexis Legal & Professional
LexisNexis® Legal & Professional provides legal, regulatory, and business information and analytics that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis® and Nexis® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,800 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.
Contact Information
Name: Matthew Leopold
Email: matthew.leopold@lexisnexis.co.uk
Job Title: Head Of Brand And Comms
National Advertising Division Finds Certain Native Brand Personal Care Products Claims Supported; Recommends P&G Modify or Discontinue Others
New York, NY – June 27, 2024 – In a challenge brought by SC Johnson & Son Inc. (SCJ), BBB National Programs’ National Advertising Division determined that certain claims made by Procter & Gamble Company (P&G) for its Native brand of personal care products are supported, including:
- P&Gs use of “simple” in its tagline “Clean. Simple. Effective.”
- Monadic “safe” claims such as “safe & simple products made without harsh ingredients.”
However, the National Advertising Division (NAD) recommended that P&G:
- Modify or discontinue use of “simple ingredients” when describing Native product ingredients for its deodorants, body washes, body lotion, conditioners, and shampoos.
- Discontinue its “Born in the USA” claim.
SCJ, maker of the Method brand of products, challenged claims found on product packaging, advertising, and Amazon listings for P&G’s Native brand of personal care products.
“Simple” Claims
The National Advertising Division (NAD) determined that one message reasonably conveyed by “simple” in Native’s tagline, “Clean. Simple. Effective,” is that Native products contain few or minimal ingredients. NAD found that P&G substantiated the claim and determined use of the tagline is substantiated in the context of Native’s product packaging and website.
SCJ also challenged Native’s use of “simple” in reference to individual ingredients in Native Products instead of the product formulations as a whole: “simple ingredients,” “simple & effective ingredients,” or “simple ingredients you can understand at a glance.” NAD determined the description of Native ingredients as “simple” is not supported for its deodorants, body washes, body lotion, conditioners, and shampoos and recommended that P&G discontinue or modify its use of the “simple ingredients” claims when describing these products.
Safe Claims
The National Advertising Division (NAD) determined that one message reasonably conveyed by a monadic unqualified “safe” claim is that the product is safe when used as directed. NAD noted that while advertisers are responsible for all messages reasonably conveyed by their advertising, they are not obligated to support unreasonable interpretations of their claims, such as the message that the product is safe for all possible uses, even unintended ones, or that the product is safe for consumers to misuse contrary to product directions.
NAD found P&G’s monadic “safe” claims, such as “safe & simple products made without harsh ingredients” and “safe, synthetic, sustainable fragrances (free of phthalates),” used on Native products to be supported.
“Born in the USA” Claim
The National Advertising Division (NAD) determined that one message reasonably conveyed by P&G’s “Born in the USA” claim is that Native products are made in the USA. NAD noted that the Federal Trade Commission standard for “Made in USA” claims require that “all or virtually all” of the cost of the goods sold be attributable to domestic sources. Since P&G did not provide any evidence that its products are made in the USA, NAD recommended that the claim be discontinued.
During the proceeding, P&G permanently discontinued certain claims. Therefore, NAD did not review these claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, though P&G “respectfully disagrees” with certain of NAD’s determinations, it agreed to comply with NAD’s recommendations.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Contact Information
Name: Jennie Rosenberg
Email: jrosenberg@bbbnp.org
Job Title: Media Relations
CBTD 2024 EXPECTS MORE THAN 7.000 VISITORS AT ITS 39TH EDITION
The largest congresses for HR, T&D and people development professionals in Latin America will take place from June 19 to 21 in São Paulo
The Brazilian Training and Development Association (ABTD) announces the 39th edition of the Brazilian Training and Development Congress (CBTD), which will take place from June 19 to 21 at the PRO MAGNO Events Center in São Paulo.
Aimed at all professionals who develop people, Human Resources and Training & Development, the focus of the debates at CBTD 2024 will be the abundance of possibilities, resources and tools available to achieve companies’ objectives. In addition, understanding how plurality has become a routine in the path of professionals, who need to be increasingly empowered to make faster and more strategic decisions.
“The challenge is to be strategic, broadening our systemic vision, but discerning what is essential to achieve our goals. While we remain aware to respond to the challenges of the present moment and drive individual and collective growth, we must not forget to be human, so that by developing and delivering our potential, we can contribute to promoting more inclusive and collaborative environments, the only way to build a sustainable future,” says Igor Cozzo, executive director of ABTD.
During the three days of the event, attendees will have at their disposal more than 250 activities spread over 16 stages, delivered by more than 200 speakers in different formats of learning experiences, mixing expository and interactive methodologies, with durations ranging from 15 minutes, with TED Talks-style lectures, to 3 hours of immersion in experiential laboratories, as well as recorded lectures, which can be accessed via the event’s digital platform or the app, available in the Apple and Google stores.
The content that makes up the Congress grid is subject to a selection process conducted by a committee of professionals from the sector and is distributed in four areas of knowledge: Learning Methodologies and Processes, Human Capital, Leadership Development and Training Program Evaluation.
EXPO CBTD 2024, the congress’ trade fair, is free of charge and 60% bigger than in 2023. It will feature more than 80 exhibitors bringing new products and services for T&D, as well as talks offered by the event’s sponsors, sharing insights and content developed so that visitors can interact and find the best solutions for their business challenges.
Adriana Chambon, ABTD’s commercial director, talks about the importance of keeping EXPO CBTD free of charge and having spaces for visitors to share knowledge: “We believe that developing people is much more than a shared mission between ABTD, HR and T&D leaders and professionals. It is part of the purpose of being human and that’s why we try to add this value to as many people as possible”.
For more information, visit the event’s website.
ABOUT CBTD 2024
CBTD 2024 is the 39th edition of the largest Training and Development Congress in Latin America and had its most recent edition, in 2023, with 7000 participants. In addition to the lectures, workshops and plenary sessions, the Congress includes the EXPO CBTD, a trade fair for products and services, and a space for networking, which brings the latest innovations to the various players in the T&D market.
Contact Information
Name: Andréa Agune
Email: imprensa@rockbuzz.com.br
Job Title: Public Relations
National Advertising Division Recommends Agendia Modify or Discontinue Certain Claims for MammaPrint and BluePrint Breast Cancer Tests
New York, NY – June 13, 2024 – In a challenge brought by Genomic Health, Inc., a wholly owned subsidiary of Exact Sciences Corporation (GHI), BBB National Programs’ National Advertising Division recommended that Agendia, Inc. modify or discontinue certain claims regarding the superiority of its MammaPrint and BluePrint tests for black women, including claims that GHI’s Oncotype DX test is inappropriate for black women and that it is biased, inaccurate, and inconsistent.
GHI’s Oncotype DX test and Agendia’s MammaPrint and BluePrint genomic tests assess the risk of breast cancer recurrence in early-stage breast cancer patients.
The challenged claims appeared in sponsored advertising content, in posts on all major social media platforms, and on the Agendia website. Agendia’s advertisements are provided to doctors, other medical professionals, breast cancer patients, and caregivers.
Equality of Care/Bias Claims
GHI challenged a two-sided postcard distributed to healthcare professionals with the headline that Agendia and its tests provide “EQUAL CARE FOR ALL” and that “Agendia is committed to addressing racial disparities in breast cancer,” followed by claims including:
- “Black women are more likely to die from breast cancer than white”
- “Only MammaPrint & BluePrint results can identify higher risk ER+ tumors in black women”
- “Agendia’s test provide consistent results in black women as well as in other diverse groups of patients”
- “Oncotype DX Breast RS test has lower prognostic accuracy in Black women”
The bottom of the postcard says, “Not all Genomic Tests are Created Equal.”
The other side of the postcard shows a comparative chart between the “MammaPrint & BluePrint” vs. “Onctoype DX” and a series of checkmarks indicating differences between the tests. The chart concludes with the claim “EQUAL CARE FOR ALL” checked “yes” for MammaPrint & BluePrint, with no checkmark for Oncotype DX.
The National Advertising Division (NAD) determined that at least one message reasonably conveyed by this advertisement and comparative chart is that GHI does not want equal care for all, a message not supported by the evidence in the record.
Further, NAD concluded that Agendia’s evidence does not provide a reasonable basis for the claim that the Onctoype DX test is biased (along with the negative connotation implied by the word “bias”) and that the MammaPrint test has uncovered this bias.
Therefore, NAD recommended Agendia either discontinue these claims or modify its advertising to avoid conveying the falsely disparaging messages that GHI does not want equal care for all and that its Onctoype DX test is biased.
Superiority/Singularity for Tumor Identification Claims
The National Advertising Division (NAD) determined that Agendia’s evidence does not provide a reasonable basis for the overly broad message conveyed by the claim “Only MammaPrint & BluePrint results can identify higher risk ER+ tumors in black women,” which appeared on the postcard. Therefore, NAD recommended that Agendia either discontinue the claim or modify it to more accurately reflect the underlying support.
Accuracy of Test Results/Inconsistent Results Claims
The National Advertising Division (NAD) recommended Agendia discontinue claims that MammaPrint results provide “more accurate predictions” because the evidence does not support that it is “more” accurate than either prior or competing tests and because the test is not cleared or indicated as a predictive test.
GHI also challenged several claims questioning the reliability of Oncotype DX, a test that Agendia characterized as having lower accuracy in black women and inconsistent results.
NAD determined that the studies Agendia relied on are not a good fit for claims that broadly communicate that Onctotype DX has lower prognostic accuracy or worse outcomes for black women.
Therefore, NAD recommended Agendia discontinue the challenged claims or modify its advertising to avoid conveying the overly broad message that Oncotype DX has lower prognostic accuracy and provides less consistent results for black women than MammaPrint and BluePrint. NAD noted that nothing in its decision prevents Agendia from accurately communicating the results of the studies in a more narrowly tailored manner.
Worse Outcomes for Black Women Claims
The National Advertising Division (NAD) recommended that Agendia discontinue claims that attribute worse outcomes for black women with the same Oncotype DX test results as white women or modify the claims to avoid conveying such a message.
Material Connection Disclosures
GHI asserted that Agendia posted articles published by Hit Consultant and Stat News featuring Dr. Johnson’s opinions on MammaPrint and Oncotype tests on social media that do not include the material connection disclosures required by the FTC’s Guides Concerning Use of Endorsements and Testimonials in Advertising. Since Agendia confirmed that it does not have a relationship, paid or otherwise, with Dr. Johnson, Stat News, or Hit Consultant, the National Advertising Division (NAD) determined there are no material connection disclosures required on the challenged posts.
In its advertiser statement, Agendia stated that it will comply with NAD’s recommendations although it “respectfully disagrees with NAD regarding both the interpretation of and the substantiation for Agendia’s advertising” and “has no current plans to resume the challenged claims.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Contact Information
Name: Jennie Rosenberg
Email: jrosenberg@bbbnp.org
Job Title: Media Relations
LexisNexis launches Lexis+ AI to the UK legal market
Grounded on LexisNexis’ vast legal research and practical guidance content, following a successful preview, Lexis+ AI is now commercially available in the UK, delivering fully encrypted, secure interactions with accurate results in seconds.
LONDON, 13th June 2024 – LexisNexis® Legal & Professional, a leading global provider of legal information and analytics, today announced that Lexis+ AI is now generally available for UK customers. This follows the successful commercial launches of Lexis+ AI in both the USA and Australia.
Lexis+ AI delivers trusted results in a familiar, easy-to-use interface that combines the power of generative AI with proprietary search technology. Lexis+ AI answers are grounded in one of the world’s largest repositories of reliable and exclusive legal content from LexisNexis, including primary, secondary, analytical content and expansive Practical Guidance modules.
Lexis+ AI provides direct links in its responses to the underlying citable authority. This allows users to instantly validate results, reducing the risk of invented content, or hallucinations. Lexis+ AI automatically checks all linked citations against LexisNexis’ content to ensure they are valid.
Developed with input from leading global law firms such as Macfarlanes, Eversheds Sutherland (International), Pinsent Masons and CMS UK, Lexis+ AI has been built to meet the day-to-day needs of lawyers. Eleanor Windsor, Partner, Director of Knowledge Management, at Irwin Mitchell commented “we selected Lexis+ AI as it is the most advanced legally-trained AI solution on the market. It will enable us to maximise the value of the legal intelligence we already access from LexisNexis.”
The solution’s AI capabilities were built internally at LexisNexis with world-leading tech partnerships, enabling the company to rapidly introduce new features and technology and provide customers with a seamlessly integrated experience across the LexisNexis ecosystem.
Lexis+ AI features conversational search, intelligent legal drafting, insightful summarisation, and document upload capabilities, all supported by state-of-the-art encryption and privacy technology to keep sensitive data secure:
- Conversational search simplifies complex and time-consuming legal research by enabling users to conversationally interact with Lexis+ AI, explore new insights, and ask for adjusted and refined output.
- Document drafting instantly produces contract clauses and client communications from a simple user prompt.
- Summarisation functionality delivers case summaries in seconds with more content and capabilities coming soon.
- Document upload capabilities enable users to rapidly analyse, summarise and extract key insights from legal documents.
Lexis+ AI offers industry-leading data security and attention to privacy. Uploaded documents are always purged at the end of each session and users can easily manage or delete their prompt conversation history. The solution is continually improving, with LexisNexis legal subject matter experts regularly sampling hundreds of thousands of AI generated answers, to tune and educate the model. LexisNexis employs over 2,000 technologists, data scientists and subject matter experts to develop, test, and validate its solutions and deliver comprehensive, accurate information.
“This is a pivotal moment in the history of the UK legal industry. We are delighted to deliver a generative AI solution that will safely and securely enable our customers’ success,” said Gerry Duffy, Managing Director of LexisNexis UK. “We have had unprecedented levels of interest in Lexis+ AI from our market and as of today, many of our customers will be enjoying the competitive advantage of having access to our rich and authoritative content combined with our leading AI technology”.
LexisNexis is responsibly developing legal AI solutions with human oversight. LexisNexis, part of FTSE listed RELX, follows the RELX Responsible AI Principles. These require the business to consider the real-world impact of its solutions on people and to take proactive action to prevent the creation or reinforcement of unfair bias.
For more information on Lexis+ AI or for a demo visit www.lexisnexis.co.uk/lexis-plus/lexis-plus-ai.html
About LexisNexis Legal & Professional
LexisNexis® Legal & Professional provides legal, regulatory, and business information and analytics that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis® and Nexis® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,800 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.
Media Contact
Matthew Leopold
Head of Communications
LexisNexis
Matthew.Leopold@lexisnexis.co.uk
+447788435569
Following National Advertising Division Challenge, Perfect Play Voluntarily Discontinues Earnings Claim for Solitaire Smash Mobile App Game
New York, NY – June 12, 2024 – Following a challenge brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, Perfect Play Ltd. voluntarily discontinued the claim that consumers can win significant amounts of money by playing its Solitaire Smash mobile app game.
The National Advertising Division’s (NAD) monitoring program focuses on, among other things, advertising to vulnerable consumers. At issue is the claim “During the day I work at the bookstore, but at night I play Solitaire Smash tournaments. [I earn] $140,000 a year.” NAD’s inquiry focused on claims that imply that individuals who play Solitaire Smash can typically earn a significant amount of money akin to a supplemental salary.
In response to the challenge, Perfect Play stated that all challenged claims were permanently discontinued and that it has appointed a compliance officer responsible for monitoring advertising going forward. Therefore, NAD did not review the claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, Perfect Play stated that it “appreciates NAD bringing this matter to its attention and is pleased to have resolved NAD’s concerns.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Contact:
Jennie Rosenberg
Media Relations
BBB National Programs
press@bbbnp.org
National Advertising Division Recommends Telecom Business Solutions Modify its AI-Pro Advertising to Avoid Confusion with ChatGPT and OpenAI
New York, NY – June 11, 2024 – BBB National Programs’ National Advertising Division recommended, as part of its routine monitoring program, that Telecom Business Solutions, Inc. d/b/a AI-Pro.org, modify its AI-Pro advertising, which uses the terms “ChatGPT” and “GPT4,” to avoid confusion about the nature of AI-Pro’s products and services and its relationship with OpenAI.
AI-Pro is not OpenAI but utilizes OpenAI’s ChatGPT 3.5 and ChatGPT 4.0 technology through application programming interfaces (APIs). By integrating OpenAI’s technology into some of AI-Pro’s applications, AI-Pro provides users access to OpenAI’s ChatGPT.
During the proceeding, AI-Pro agreed to voluntarily modify the challenged express claims. NAD determined that AI-Pro’s modified claim “Powered by OpenAI,” “Powered by ChatGPT Technology,” accompanied by the disclosure “Independently developed and not affiliated, endorsed, or sponsored by OpenAI” makes clear that AI-Pro uses ChatGPT technology in its product offerings and is not ChatGPT.
However, NAD found that in contexts without the disclosure, or in which the disclosures are not clear and conspicuous, consumers can reasonably take away the message that AI-Pro’s product or service is ChatGPT or is affiliated with OpenAI.
Therefore, NAD recommended that:
- The disclosure “AI-PRO is Powered by OpenAI. We are not affiliated nor related to OpenAI” be clear and conspicuous, or
- That the advertising otherwise make clear that AI-Pro provides applications built on OpenAI and ChatGPT and that its APIs are not the same as or provided by OpenAI or ChatGPT.
In its advertiser statement, Telecom Business Solutions stated that it agrees to comply with NAD’s recommendations and noted that “while it has made some modifications, it will make additional ones in accordance with the NAD decision.”
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Contact:
Jennie Rosenberg
Media Relations
BBB National Programs
press@bbbnp.org
National Advertising Division Finds Certain Claims for Early Defense Dietary Supplement Supported; Recommends Others be Modified or Discontinued
New York, NY – June 6, 2024 – In a challenge brought by MacuHealth LP, BBB National Programs’ National Advertising Division determined that Vision Elements, Inc. substantiated shelf-life stability and safety claims for its Early Defense dietary supplement.
However, the National Advertising Division (NAD) recommended that other challenged claims be discontinued or modified.
Vision Element’s Early Defense product contains a triple carotenoid formula as its active ingredient, along with other excipients, and is marketed to support healthy eyesight.
Published Studies Claim
The National Advertising Division (NAD) determined that one reasonable takeaway from Vision Element’s claim “Science-Driven Formulas developed from peer-reviewed, published studies” is that Early Defense’s formula is the same as that tested in peer reviewed published studies.
Since there was no evidence in the record that Early Defense’s formula has been the subject of peer-reviewed published studies, NAD recommended the claim be discontinued. NAD noted that nothing in its decision prevents Vision Elements from claiming that the ingredients were developed from peer-reviewed published studies provided that the claim is properly substantiated.
Performance Claims
The National Advertising Division (NAD) concluded that there was no evidence to support the challenged claim that Early Defense “helps maintain healthy eyesight and visual performance” because the studies and meta-analysis relied on by the advertiser were not conducted on the Early Defense product. Therefore, NAD recommended the claim be discontinued but noted that nothing in its decision prevents Vision Elements from tailoring its claims to the benefits specific ingredients in Early Defense can provide, as long as the claims are substantiated by competent and reliable scientific evidence.
NAD also recommended that Vision Elements remove the patient testimonial from its website stating, “I have been taking Early Defense capsules since January… I have great clarity, contrast and colour tone” due to a lack of evidence in the record.
Bioavailability and Absorption Claims
MacuHealth challenged the claim “Liquid-Filled Hard Capsules: Advanced encapsulation technology helps protect the carotenoids through shelf-life and aid absorption.”
The National Advertising Division (NAD) found Vision Element’s evidence shows that liquid-filled hard capsules are generally accepted by scientists to help maintain a product’s shelf-life stability without impacting absorption. Therefore, NAD determined that Vision Elements has a reasonable basis for the claim “Liquid-Filled Hard Capsules: Advanced encapsulation technology helps protect the carotenoids through shelf-life” but recommended it modify the portion of the claim that the technology will “aid absorption” to better fit the evidence.
NAD concluded the claim that “Vision Elements liquid-filled capsules naturally enhance carotenoid absorption and bioavailability with a combination of olive oil and non-GMO sunflower lecithin” is not supported by the record and recommended it be discontinued.
Shelf-Life Stability & Safety Claims
The National Advertising Division (NAD) found that testing of the Early Defense product for harmful substances, the FDA’s Generally Recognized As Safe (GRAS) information on individual ingredients and product testing on Early Defense for potency, even after the product is on shelves, is enough to constitute competent and reliable scientific evidence that multiple tests are conducted to assess for safety and potency.
Therefore, NAD found that Vision Elements substantiated claims that:
- “Purity content and shelf-life stability are proven over and again through extensive ongoing quality control testing”; and
- “Multiple tests are performed throughout the production process to ensure safety and potency.”
In its advertiser statement, Vision Elements stated that it agrees to comply with NAD’s recommendations although it respectfully disagrees with certain of NAD’s conclusions.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. The National Advertising Division reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Contact Information:
Name: Jennie Rosenberg
Email: jrosenberg@bbbnp.org
Job Title: Media Relations
Following National Advertising Division Challenge, Summus Medical Laser Voluntarily Discontinues Certain Claims
New York, NY – June 4, 2024 – Following a BBB National Programs’ National Advertising Division challenge brought by competitor Multi Radiance Medical, Summus Medical Laser voluntarily discontinued certain claims for its Medical Laser product.
Multi Radiance Medical challenged claims that it argued were outside the indications allowed by the Food and Drug Administration (FDA) for devices registered under product code ILY for temporary relief of minor muscle and joint pain, arthritis, and muscle spasms, relieving stiffness, promoting relaxation of muscle tissue, and to temporarily increase local blood circulation where heat is indicated.
In response to the challenge, Summus stated that it is permanently discontinuing the challenged claims. Therefore, the National Advertising Division (NAD) did not review the claims on their merits and will treat the claims, for compliance purposes, as though NAD recommended they be discontinued.
In its advertiser statement, Summus stated that it agrees to comply with NAD’s recommendations and appreciates the opportunity to participate in the self-regulatory process.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. This press release shall not be used for advertising or promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than a dozen globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create a fairer playing field for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Contact Information
Name: Jennie Rosenberg
Email: jrosenberg@bbbnp.org
Job Title: Media Relations
LexisNexis to Acquire Document Drafting Tech Provider Henchman
Acquisition will combine Henchman’s Document Management System data enrichment with trusted LexisNexis drafting guidance content to deliver personalized generative AI experience
NEW YORK, June 3, 2024 – LexisNexis Legal & Professional®, a leading global provider of information and analytics, today announced it has agreed to acquire Henchman, a legal tech company that enriches data from Document Management Systems (DMS) for faster document drafting. Henchman is a Belgium-based company, founded in 2020, with 170+ legal and corporate customers globally including top U.S. and European law firms and companies.
By acquiring Henchman, LexisNexis will deliver personalized generative AI solutions to customers around the world. Henchman core product functionality will be available to existing and new customers. LexisNexis has immediate plans to utilize Henchman’s technology with its proprietary Retrieval Augmented Generation 2.0 (RAG 2.0) platform in its flagship Lexis+ AI solution, enabling the use of trusted customer data as grounding data for generative AI drafting. Henchman’s capabilities will also be added to Lexis® Create, the Microsoft 365 add-in solution that enables point-of-workflow integration for generative AI drafting in Microsoft Word, Outlook, Teams and Copilot.
Henchman is used by leading law firms and corporations to enrich internal work product, creating a layer of intelligence on contract databases to accelerate drafting tasks.
Henchman interacts with the DMS of a law firm or corporation, indexing the organization’s precedent documents at the clause level, making the data available for contract insights and drafting. Its technology works with legal-specific DMS providers and general enterprise content management systems and is language agnostic. Henchman’s technology incorporates security and conflict settings that mirror document permissions within the DMS, preserving firm confidentiality and privacy requirements. These benefits are available to customers in days, not months, from deployment of the technology.
Advanced technology processes allow a customer to quickly find key insights from internal data repositories. LexisNexis will incorporate this enhanced document enrichment capability to deliver new generative AI drafting solutions.
“This is an exciting moment for our customers and the LexisNexis and Henchman teams,” said Mike Walsh, CEO, LexisNexis Legal & Professional. “We’re continuously engaging with customers to determine where AI can deliver the most value. Now, we’ll be able to address one of our legal customers’ top requests – to have searchable internal firm data, combined with our current drafting and AI offerings, allowing legal professionals to rapidly extract language and insights, and generate higher quality work using both internal data and LexisNexis solutions together.”
Henchman Co-Founder Gilles Mattelin added, “We see this union with LexisNexis as an extension of our drafting vision to proactively surface valuable and strategic insights for customers – delivering a center of knowledge to legal teams. We believe the combination of our teams and tech will empower customers to make informed decisions faster, generate outstanding work, and drive economic value for their organizations.”
Closing of the transaction is subject to customary regulatory consents and is expected early in the second half of 2024. The terms of the transaction have not been disclosed.
LexisNexis is responsibly developing legal AI solutions with human oversight. LexisNexis, part of RELX, follows the RELX Responsible AI Principles, considering the real-world impact of its solutions on people and taking action to prevent the creation or reinforcement of unfair bias.
Lexis+ AI delivers trusted results with state-of-the-art encryption and privacy technology to keep data secure. Using an extensively enhanced LexisNexis proprietary RAG 2.0 platform, Lexis+ AI responses are grounded in the world’s largest repository of up-to-date legal content which ensures the highest-quality answer with the most up-to-date validated citation references. Uploaded documents are always purged at the end of each session and users can easily manage or delete their prompt conversation history. The solution is continually improving with hundreds of thousands of rated answer samples by LexisNexis legal subject matter experts used for model tuning. LexisNexis employs over 2,000 technologists, data scientists, and subject matter experts to develop, test, and validate its solutions and deliver comprehensive, authoritative information.
For more information on Lexis+ AI and our generative AI resources for legal professionals, visit www.lexisnexis.com/ai.
About LexisNexis Legal & Professional
LexisNexis® Legal & Professional provides legal, regulatory, and business information and analytics that help customers increase their productivity, improve decision-making, achieve better outcomes, and advance the rule of law around the world. As a digital pioneer, the company was the first to bring legal and business information online with its Lexis® and Nexis® services. LexisNexis Legal & Professional, which serves customers in more than 150 countries with 11,800 employees worldwide, is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.
Media Contact
Dana Greenstein
Director of Communications, North America & UK
LexisNexis Legal & Professional
212-448-2163
dana.greenstein@lexisnexis.com